Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 1
2013 2
2014 1
2017 3
2018 3
2019 1
2022 3
2023 4
2024 2
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

18 results

Results by year

Filters applied: . Clear all
Page 1
Rotavirus Vaccine Schedules and Vaccine Response Among Infants in Low- and Middle-Income Countries: A Systematic Review.
Gruber JF, Gruber LM, Weber RP, Becker-Dreps S, Jonsson Funk M. Gruber JF, et al. Open Forum Infect Dis. 2017 Apr 5;4(2):ofx066. doi: 10.1093/ofid/ofx066. eCollection 2017 Spring. Open Forum Infect Dis. 2017. PMID: 28567431 Free PMC article. Review.
Our objective was to review the literature evaluating the effects of monovalent (RV1) or pentavalent rotavirus vaccines schedules on vaccine response. METHODS: We searched PubMed, Web of Science, Embase, and ClinicalTrials.gov for eligible trials conducted in LMICs compari …
Our objective was to review the literature evaluating the effects of monovalent (RV1) or pentavalent rotavirus vaccines schedules on …
Long COVID Risk and Pre-COVID Vaccination: An EHR-Based Cohort Study from the RECOVER Program.
Brannock MD, Chew RF, Preiss AJ, Hadley EC, McMurry JA, Leese PJ, Girvin AT, Crosskey M, Zhou AG, Moffitt RA, Funk MJ, Pfaff ER, Haendel MA, Chute CG; N3C and RECOVER Consortia. Brannock MD, et al. medRxiv [Preprint]. 2022 Oct 7:2022.10.06.22280795. doi: 10.1101/2022.10.06.22280795. medRxiv. 2022. Update in: Nat Commun. 2023 May 22;14(1):2914. doi: 10.1038/s41467-023-38388-7. PMID: 36238713 Free PMC article. Updated. Preprint.
Our results bolster the growing consensus that vaccines retain protective effects against long COVID even in breakthrough infections. KEY POINTS: Question: Does vaccination prior to COVID-19 onset change the risk of long COVID diagnosis?...
Our results bolster the growing consensus that vaccines retain protective effects against long COVID even in breakthrough infections. …
A systematic review of whether COVID-19 randomized controlled trials reported on demographic and clinical characteristics.
Pak J, Lund JL, Keil A, Westreich D, Stürmer T, Wohl D, Farel C, Drummond MB, Webster-Clark M. Pak J, et al. Pharmacoepidemiol Drug Saf. 2022 Dec;31(12):1219-1227. doi: 10.1002/pds.5533. Epub 2022 Oct 5. Pharmacoepidemiol Drug Saf. 2022. PMID: 35996832 Free PMC article.
Most of the RCTs (113/149) studied potential treatments, while fewer studied vaccines (29), prophylaxis strategies (5), and interventions to prevent transmission among those infected (2). ...
Most of the RCTs (113/149) studied potential treatments, while fewer studied vaccines (29), prophylaxis strategies (5), and intervent …
Vaccine patterns among patients diagnosed with Guillain-Barré Syndrome and matched counterparts in a Medicare supplemental population, 2000-2020.
Eiffert SR, Stürmer T, Thorpe CT, Traub R, Raman SR, Pate V, Kinlaw AC. Eiffert SR, et al. Vaccine. 2023 Sep 7;41(39):5763-5768. doi: 10.1016/j.vaccine.2023.08.014. Epub 2023 Aug 10. Vaccine. 2023. PMID: 37573203 Free PMC article.
Some vaccines have a small risk of Guillain-Barre Syndrome (GBS), a rare autoimmune disorder characterized by paralysis if untreated. ...Prior to GBS diagnosis, the wMCC of vaccines per person was similar between GBS cases and matched counterparts, but after two yea …
Some vaccines have a small risk of Guillain-Barre Syndrome (GBS), a rare autoimmune disorder characterized by paralysis if untreated. …
Vaccine patterns among older adults with Guillain-Barré syndrome and matched comparators, 2006-2019.
Eiffert SR, Kinlaw AC, Sleath BL, Thorpe CT, Traub R, Raman SR, Stürmer T. Eiffert SR, et al. J Am Geriatr Soc. 2024 Oct;72(10):3055-3067. doi: 10.1111/jgs.19110. Epub 2024 Aug 1. J Am Geriatr Soc. 2024. PMID: 39090827
BACKGROUND: Some vaccines have a small risk of triggering Guillain-Barre syndrome (GBS), an autoimmune disorder where nerve damage leads to paralysis. ...The wMCCs in the 1 year before the index date were similar for both groups, with a wMCC of 74 vaccines/100 peopl …
BACKGROUND: Some vaccines have a small risk of triggering Guillain-Barre syndrome (GBS), an autoimmune disorder where nerve damage le …
Timing of Rotavirus Vaccine Doses and Severe Rotavirus Gastroenteritis Among Vaccinated Infants in Low- and Middle-income Countries.
Gruber JF, Becker-Dreps S, Hudgens MG, Brookhart MA, Thomas JC, Jonsson Funk M. Gruber JF, et al. Epidemiology. 2018 Nov;29(6):867-875. doi: 10.1097/EDE.0000000000000909. Epidemiology. 2018. PMID: 30074540 Free PMC article. Clinical Trial.
We analyzed data from clinical trials of the monovalent (RV1) and pentavalent (RV5) rotavirus vaccines in low- and middle-income countries to understand the association between vaccine dose timing and severe rotavirus gastroenteritis incidence. ...
We analyzed data from clinical trials of the monovalent (RV1) and pentavalent (RV5) rotavirus vaccines in low- and middle-income coun …
Direct, indirect, total, and overall effectiveness of the rotavirus vaccines for the prevention of gastroenteritis hospitalizations in privately insured US children, 2007-2010.
Panozzo CA, Becker-Dreps S, Pate V, Weber DJ, Jonsson Funk M, Stürmer T, Brookhart MA. Panozzo CA, et al. Am J Epidemiol. 2014 Apr 1;179(7):895-909. doi: 10.1093/aje/kwu001. Epub 2014 Feb 26. Am J Epidemiol. 2014. PMID: 24578359 Free PMC article.
We demonstrate how direct, indirect, total, and overall effectiveness estimates and absolute benefits of rotavirus vaccines vary through the years following vaccine introduction. Privately insured US children in a large claims database were followed from age 8 months until …
We demonstrate how direct, indirect, total, and overall effectiveness estimates and absolute benefits of rotavirus vaccines vary thro …
18 results